Bone marrow (BM) and peripheral blood (PS) cells from patients with juvenile chronic myelogenous leukemia (JCML) exhibit spontaneous in vitro proliferation. Several cytokines including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-18 (IL-la), and tumor necrosis factor alpha (TNFa) have been implicated in supporting the growth of leukemic monocyte-macrophage colonies either by autocrine or paracrine pathways. In seven untreated JCML patients, we investigated the role of IL-l in the spontaneous growth of these cells by specifically blocking IL-l receptors. The IL-l receptor antagonist (IL-lRa) was added to the clonogenic assays, and in each case significant (mean = 63%. range = 35% to 82%) inhibition of spontaneous proliferation was observed. Uncultured circulating cells from PB or BM of four out of five pa-
tients expressed IL-18-specific mRNA and secreted the protein into the culture supernatants. Moreover, by means of reverse transcriptase-polymerase chain reaction (RT-PCR). we demonstrated that most of the spontaneously growing leukemic colony-forming unit cells (CFU-C) obtained from BM cells of t w o patients were positive for the presence of the IL-18-specific mRNA. Despite the presence of a measurable amount of GM-CSF in JCML cell culture supernatants, GM-CSF-specific mRNA in CFU-C cells of four cases was not detected by RT-PCR. These data further support a central role for IL-18 in the pathogenesis of JCML and suggest that the use of IL-l Ra could represent a novel therapeutic strategy against this disorder. of the JCML cell proliferation remains unclear; moreover, no definitive evidence has been provided on the cell source of these growth factor molecules. A naturally occurring IL-1 inhibitor has been purified, cloned, and renamed IL-I receptor antagonist .6 This molecule has been shown to inhibit the in vitro growth of leukemic cells isolated from both AML and CML during the accelerated phase of the disea~e."~ Based on these findings, we investigated gene and protein expression of IL-1 p and GM-CSF in cells and clonogenic progenitors in these patients and the effect of IL-l blockade on spontaneous growth using IL-I Ra.
MATERIALS AND METHODS
Patients. Between January 1986 and December 1992, the eight patients in this study were referred to our clinic. Table 1 summarizes the main clinical and laboratory data that fit into the classic description of JCML.* These patients had varying degrees of hepatosplenomegaly, skin manifestations, and hemorrhagic signs. Most had leukocytosis, monocytosis, anemia, and a high level of fetal hemoglobin. BM aspirates showed normal cellularity with myeloid hyperplasia when BM smears were stained with May-Griinwald Giemsa. Cytogenetic analysis of BM cells revealed an apparently normal karyotype. For control studies, BM was obtained from five pediatric patients with classic Ph" CML and 10 normal children undergoing marrow harvesting for allogeneic BM transplantation. Approval was obtained from the Institutional Review Board for these studies. Informed consent was obtained according to the Declaration of Helsinki.
Cell preparations. Peripheral blood (PB) or BM cells were isolated on Ficoll-Hypaque (Pharmacia, Piscataway, NJ) density gradients and used for cell cultures and molecular studies. In selected experiments, PB or BM mononuclear adherent cells were removed by overnight incubation in plastic flasks (Falcon, Becton Dickinson, Plymouth, UK) in Iscove's modified Dulbecco's medium ([IMDM] Gibco, Paisley, Scotland, UK) with 10% fetal calf semm at 37°C to achieve a satisfactory depletion of adherent cells. Nonadherent cells were removed and contained less than 5% of monocytes as assessed by detecting the presence of the CD 14 antigen using the M02 antibody (kindly provided by Dr R.F. Todd, University of Michigan, Ann Arbor, MI) by flow cytometry. The light-density cell fractions and depleted cell populations were then plated in clonogenic assays. t Normal values, 1 1 to 94.
5 X 105/mL, respectively, were plated in IMDM supplemented with 20% fetal calf serum, +lo% 5637 conditioned medium, and 0.33% final concentration of Agar Bacto (Difco Laboratories, Detroit, MI) as previously described? The conditioned medium from the 5637 tumor cell line was used as a source of CSFs at a final concentration of 10%. All samples were cultured in the presence and absence of CSFs. The culture mixture was plated in a volume of 1 mL in 35-mm Petri dishes in triplicate. After a I4day incubation at 37°C in a fully humidified atmosphere of 5% CO2 in air, colony-forming unit cells (Cm-C) were scored under an inverted microscope. Aggregates of more than 50 cells were evaluated as colonies.
To test the ability of the I L 1 Ra to inhibit the clonogenic growth of JCML cells, recombinant IL-1 Ra (kindly provided by Dr Daniel Tracey, Upjohn, Kalamazoo, MI) was added to the plates at concentrations ranging from 100 ng/mL to 1 &mL in the absence of 5637 conditioned medium. The specificity of the inhibitory effett of IL-lRa and the lack of toxic contaminants in the preparation used was confirmed by clonogenic assay performed with normal BM stimulated with 5637 conditioned medium. To characterize the aggregates, cytocentrifuged preparations of individual colonies plugged from the plate were stained with May-Griinwald Giemsa for morphologic evaluation. Nonspecific a-naphthyl acetate and chloroacetate esterase staining and immunocytochemical analysis were used to identify the nature of colony-forming cells (Sigma Italia, Milano, Italy). The expression of surface antigens was assessed by the alkaline phosphatase anti-alkaline phosphatase (APAAP) technique, as previously described." A neutralizing monoclonal anti-human GM-CSF (clone 3092)'' was provided by Dr J. Griffin (Dana Farber Cancer Institute, Boston, MA).
Molecular studies. Northern blot analysis was performed as previously described." The cDNA for the IL-l Ra was obtained by polymerase chain reaction (PCR) using mRNA from AML193 cells as substrate. 13 The IL-lB and GM-CSF cDNA probes were kindly provided by Dr Steven Clark (Genetics Institute, Cambridge. MA). cDNA probes were labeled with 32P-deoxycytidine triphosphate by the method of Feinberg and Vogel~tein.'~ in selected experiments, total mRNA was directly isolated from JCML colonies after 14 days of culture, using the acid guanidium thiocyanatephenol-chloroform method as previously desc~ibed.'~ Briefly, 200 p L guanidium buffer and 4 pg MS2 phage RNA (Boehringer, Mannheim, Germany) as a carrier were added to individual colonies following removal from agar. RNA was then extracted once by mixing with 200 pL phenol40 pL chloroform-isoamylic alcohol. After 1 centrifugation at 17,000 g for 20 minutes at 4"C, supernatant was precipitated with 2 v01 100% ethanol and finally resuspended in 20 pL of buffer for cDNA synthesis. In vitro reverse transcription of RNA to cDNA was performed in a 20-pL volume for 15 minutes at 42°C containing 2.5 U cloned Moloney murine leukemia virus reverse transcriptase and oligo deoxyribosylthymine as primers, using a commercial kit (GeneAmp RNA PCR kit, Perkin ElmerCetus, Norwalk, CT) according to manufacturer's conditions. A volume of 5 pL was then diluted in 100 pL final volume of buffer mixture containing 50 mmol/L KCl, I O mmol/L Tris hydrochloride (pH 8.3 at 25"C), 2 mmol/L MgCI2, 200 pmol/L deoxyadenosine triphosphate, deoxyguanosine triphosphate, deoxycytidine triphosphate, and deoxyribosylthymine triphosphate, 30 pmol ofeach primer, and 2.5 U Thermus Aquaticus DNA polymerase. The reaction was performed in a Thermal Cycler (Perkin Elmer-Cetus, Norwalk, CT) for 45 cycles; after the first 30 cycles, one fifth of the reaction mixture was removed and substituted with fresh reagents for the successive 15 cycles. The PCR temperatures used for each cycle were as follows: 95°C for 5 minutes as the denaturation step; then 95T, 60'C, and 72°C for 1 minute each; and finally 10 minutes at 72°C. The primers used for IL-lP, included in a commercial kit (Perkin Elmer-Cetus), were 5'AAACAGATGAAGTGCTCCTT-CCAGG-3' and 5"TGGAGAAACACCACTTGTTGCTCCA-3'. The primers used for GM-CSF were 5'-CTGCACCCGCCC-GCTCG-3' corresponding to the 442 through 426 nucleotide residues and 5'-CACTCCTGGACTGGCTC-3' corresponding to residues 58 to 74 ofthe published GM-CSF sequence. 16 Ten microliters of PCR mixture was run on a 1.8% Nusieve agarose gel (FMC BioProducts, Rockland, ME) stained with ethidium bromide and visualized under a UV lamp. In selected experiments, IO pL PCR products fractionated by electrophoresis through a 1.8% agarose gel was transferred to nylon membranes (Genescreen Plus, New England Nuclear, Boston, MA). Prehybridization, hybridization, and washings were performed according to manufacturer's instructions as previously reported."
Measuremenl of cytokine produdion. IL-Ip and GM-CSF levels were measured by specific, non-cross-reacting radioimmunoassays (RIAs).""* Each RIA has been validated using the cytokines in their respective biologic assay. Table 2 , when either PB or BM cells from JCML patients were cultured in the CFU-C assay, a significant number of colonies were observed in all cases in the absence of any deliberate source ofcolony-stimulating activity. By comparison, no significant growth of CFU-C was observed under the same conditions when normal or Phf CML BM cells were plated. Moreover, neither the total number nor the cell type of the colonies changed significantly when JCML cells were cultured in the presence of colony-stimulating factors. After careful depletion of adherent cells in selected experiments, a complete abrogation of the spontaneous colony growth was observed (cases no. 3, 4, 6, and 7; data not shown). The monocyte feature of JCML cells, which were growing in the absence of colony-stimulating activity, CFU-M, as indicated in Table I , was confirmed by the positive nonspecific esterase staining of a single JCML CFU-C aggregate (as shown in Fig 1 B) and by the expression of CD I4
RESULTS

Spontaneous JCML cell proliferation in vitro. As shown in
antigen on a colony as assessed by immunochemistry (Fig 1 D) .
IL-1Ra inhibits spontaneous JCML cell proliferation in vitro. To block IL-I , we considered IL-1 Ra based on our previous findings on the reduction in the spontaneous proliferation of AML cells.' As shown in Table 3 , when IL-l Ra was added to each clonogenic assay, we observed a significant inhibition of spontaneous JCML cell proliferation in each case (ranging from 35% to 82%). Increasing the concentration of IL-I Ra by I pg/mL did not result in a further abrogation of the spontaneous growth.
Cytokinegene exprcxsion in JCML cells. In light of the central role of IL-Ip in supporting JCML cells, we investigated whether JCML cells expressed the IL-I@ gene. As shown in Fig 2A, Northern analysis revealed IL-l@-specific mRNA in most cases (four of five). It is noteworthy that IL-I @ gene expression was readily observed in RNAs purified from uncultured PB. Due to the comparable kinetics of IL-I @ and IL-l Ra gene expression in normal human blood monocytes,'' we investigated the presence of IL-IRa-specific mRNA. As indicated in the representative Northern analysis shown in Fig 2B, IL-I Ra mRNA was detected in the same cases that were positive for IL-I @ gene expression. To investigate whether clonogenic cells were indeed the cellular source of IL-IB mRNA, PCR analysis of IL-I@ gene expression was performed in selected cases. Figure 3 shows a representative experiment of PCR analysis for IL-I @ gene expression conducted on six single BM colonies of patient no. 4. Superimposable results were obtained when the same experiment was performed on 12 BM colonies of patient no. 2 that were found to be consistently positive for IL-1s message. By comparison, a similar pattern of IL-IS gene expression was observed in CFU-C obtained from BM cells of normal individuals but in the presence of colony-stimulating factors (data not shown).
Because GM-CSF has also been reported to be involved in the regulation of JCML colony growth?&*' we investigated GM-CSF gene expression in PB or BM JCML cells. Specific GM-CSF mRNA was not detected by Northern blot experiments when the same mRNA preparations, found to be positive for IL-I@ or IL-l Ra gene expression, were hybridized with a GM-CSF cDNA probe (data not shown). To increase our capacity to detect GM-CSF-specific transcripts, PCR analysis was performed on total cellular RNA purified from PB and BM mononuclear cells of patients no. I, 2,4, and 7 (Fig 4) . Since the GM-CSF transcript was found in BM and PB cells of patient no. 4 only, we speculated that this could be due to contamination of a minor proportion of cells. Interestingly, when PCR analysis for GM-CSF expression was performed on six colonies from patients no. I and 4 and 12 from patient no. 2, no GM-CSF-specific mRNA was detected (data not shown). Despite the absence of GM-CSF mRNA in single JCML colony preparations, GM-CSF was detected in JCML cell culture supernatant derived from 24-and 48-hour liquid culture specimens from case no. 1 (>2.50 pg/mL). Moreover, anti-human GM-CSF induced a significant suppression (40%) of JCML colony growth in case no. 8 (data not shown). from PB mononuclear cells of a healthy donor was stimulated with phorbol 12-myristate 13-acetate (1 ng/mL) and phytohemagglutinin (10 rg/mL) for 24 hours. The amplified products (10% of the reaction mixture) were analyzed on a l .8% agarose gel, blotted onto nylon membrane, and hybridized with a oligonucleotide complementary to the GM-CSF sequence according to established procedure.
DISCUSSION
six CFU-C BM colonies of patient no. 4. As controls, PCR analysis was performed on total RNA extracted from BM mononuclear cells of the same patient (no. 4) and on total RNA from normal PB mononuclear cells stimulated with bacterial endotoxin (PBMC + LPS). The amplified products (1 0% of the reaction mixture) were analyzed on a l .8% agarose gel, visualized by ethidium bromide staining, blotted onto synthetic membrane, and hybridized with an IL-1ScDNA.
which in turn stimulated the production ofcolony-stimulating activity by accessory cells.5 In this context, it is noteworthy that the findings that either freshly obtained circulating cells or CFU-C from either PB or BM cells ofJCML patients expressed IL-I@-specific mRNA and secreted the protein in the short-term culture (data not shown). It has also been shown that IL-I cu could act directly to support JCML colony growth, but not to the same magnitude as TNFa or GM-CSF. 4 Alternatively, IL-l could exert its effect by inducing the secretion of GM-CSF and/or other growth factors, as shown for a variety of target ~e l l s . *~-*~ Several studies have implicated GM-CSF as the primary endogenous regulator of JCML cell proliferation.20 We were not able to detect GM-CSF transcripts in mRNA preparations from single JCML colonies, but, as previously reported." GM-CSF was de-U W For personal use only. on October 30, 2017. by guest www.bloodjournal.org From
